LGND Competitors & Alternatives
Compare Ligand Pharmaceuticals Incorporated with similar stocks in the same industry
Biotechnology
LGND
Main Stock$284.24
Tradestie Score
60
Market Cap
$3.49B
P/E Ratio
29.9
Revenue Growth
0.3%
Analyst Upside
+20.6%
Top Competitors
240 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABVX
Abivax SA American Depositary Shares
|
$114.78
|
$6.38B | - | 46 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$21.13
|
$6.03B | - | 39 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$57.01
|
$6.02B | - | 41 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$206.83
|
$5.92B | - | 66 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.62
|
$5.80B | 18.9 | 45 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$339.55
|
$5.20B | 42.4 | 54 | Compare |
|
ALKS
Alkermes Inc. plc
|
$48.78
|
$5.06B | 129.8 | 55 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$61.91
|
$4.94B | - | 30 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$70.28
|
$4.93B | - | 54 | Compare |
More LGND Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
240 stocks in this industry